These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 23391230
1. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand. Poonsuk K, Tribuddharat C, Chuanchuen R. Can J Microbiol; 2013 Jan; 59(1):51-6. PubMed ID: 23391230 [Abstract] [Full Text] [Related]
3. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Høiby N, Wretlind B. Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484 [Abstract] [Full Text] [Related]
4. Prevalence and mechanisms of aminoglycoside resistance among drug-resistant Pseudomonas aeruginosa clinical isolates in Iran. Saeli N, Jafari-Ramedani S, Ramazanzadeh R, Nazari M, Sahebkar A, Khademi F. BMC Infect Dis; 2024 Jul 09; 24(1):680. PubMed ID: 38982386 [Abstract] [Full Text] [Related]
5. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections. Singh M, Yau YCW, Wang S, Waters V, Kumar A. Can J Microbiol; 2017 Dec 09; 63(12):929-938. PubMed ID: 28922614 [Abstract] [Full Text] [Related]
10. Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran. Ahmadian L, Norouzi Bazgir Z, Ahanjan M, Valadan R, Goli HR. Biomed Res Int; 2021 Dec 09; 2021():7077344. PubMed ID: 34471641 [Abstract] [Full Text] [Related]
11. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plésiat P. Antimicrob Agents Chemother; 2007 Mar 09; 51(3):1016-21. PubMed ID: 17194835 [Abstract] [Full Text] [Related]
13. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Vogne C, Aires JR, Bailly C, Hocquet D, Plésiat P. Antimicrob Agents Chemother; 2004 May 09; 48(5):1676-80. PubMed ID: 15105120 [Abstract] [Full Text] [Related]
16. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. Fernández-Martínez M, Miró E, Ortega A, Bou G, González-López JJ, Oliver A, Pascual A, Cercenado E, Oteo J, Martínez-Martínez L, Navarro F, Spanish Network for the Research in Infectious Diseases (REIPI). Int J Antimicrob Agents; 2015 Aug 09; 46(2):157-63. PubMed ID: 26022930 [Abstract] [Full Text] [Related]
17. Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa. Bolard A, Plésiat P, Jeannot K. Antimicrob Agents Chemother; 2018 Feb 09; 62(2):. PubMed ID: 29133559 [Abstract] [Full Text] [Related]
18. Aminoglycoside resistance in Pseudomonas aeruginosa: the contribution of the MexXY-OprM efflux pump varies between isolates. Thacharodi A, Lamont IL. J Med Microbiol; 2022 Jun 09; 71(6):. PubMed ID: 35708991 [Abstract] [Full Text] [Related]
20. Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides. Jouybari MA, Ahanjan M, Mirzaei B, Goli HR. Rev Soc Bras Med Trop; 2021 Jun 09; 54():e05992020. PubMed ID: 33533819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]